Tamoxifen to Treat Barrett's Metaplasia

Trial Profile

Tamoxifen to Treat Barrett's Metaplasia

Discontinued
Phase of Trial: Phase 0

Latest Information Update: 16 Mar 2017

At a glance

  • Drugs Tamoxifen (Primary)
  • Indications Barrett's oesophagus
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 Jul 2016 Status changed from recruiting to discontinued.
    • 05 Apr 2015 Planned number of patients changed from 30 to 12, as reported by ClinicalTrials.gov.
    • 08 Jul 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top